Genetics, molecular mechanisms and management of long QT syndrome

Annals of Medicine

Volumn 30, Issue 1, 1998, Pages 58-65

  Wang, Qing ^a,b   Chen, Qiuyun ^a   Towbin, Jeffrey A ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiac arrhythmias; Deafness; Electrocardiogram; HERG potassium channel; KVLQT1 potassium channel; Long QT syndrome; MinK potassium channel; SCN5A sodium channel; Sudden death; Torsade de pointes

Indexed keywords

ANTIARRHYTHMIC AGENT; MEXILETINE; POTASSIUM CHANNEL; POTASSIUM ION;

ARTICLE; CHROMOSOME 11P; CHROMOSOME 21Q; CHROMOSOME 3P; CHROMOSOME 7Q; GENE MUTATION; GENETIC ANALYSIS; GENETICS; HEART ARRHYTHMIA; HEART RATE; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG QT SYNDROME; MOLECULAR BIOLOGY; MORTALITY; POTASSIUM BLOOD LEVEL; POTASSIUM CURRENT; PRIORITY JOURNAL; QT INTERVAL; SUDDEN DEATH; TORSADE DES POINTES; UNITED STATES;

EID: 0031980283     PISSN: 07853890     EISSN: None     Source Type: Journal    
DOI: 10.3109/07853899808999385     Document Type: Article

References (26)

1. Jervell A, Lange-Nielsen F. Congenital deaf mutism, functional heart disease with prolongation of the QT interval, and sudden death. Am Heart J 1957; 54: 59-78.
2. Romano C, Gemme G, Pongiglione R. Aritmie cardiache rare dell' eta pediatrica. II. Accessi sincopali per fibrillazione ventricolare parossistica. (Presentazione del primo caso della letteratura pediatrica Italians.) Clin Pediat 1963; 45: 656-83.
3. Ward OC. A new familial cardiac syndrome in children. J Ir Med Assoc 1964; 54: 103-6.
4. Romano C. Congenital cardiac arrhythmia. Lancet 1965; 1: 658-9.
5. Schwartz PJ, Periti M, Malliani A. The long QT syndrome. Am Heart J 1975; 109: 378-90.
6. Moss AJ, Schwartz PJ, Crampton R, et al. The long QT syndrome: prospective longitudinal study of 328 families. Circulation 1991; 84: 1136-44.
7. Wang Q, Shen J, Li Z, et al. Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. Hum Mol Genet 1995; 4: 1603-7.
8. Bazett HC. An analysis of the time-relationships of electrocardiograms. Heart 1920; 7: 353-70.
9. Keating MT, Atkinson D, Dunn C, Timothy K, Vincent GM, Leppert M. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science 1991; 252: 704-6.
10. Jackman WM, Clark M, Friday KJ, Aliot EM, Anderson J, Lazzara R. Ventricular tachyarrhythmias in the long QT syndromes. Med Clin North Am 1984; 68: 1079-109.
11. Kossmann CE. The long QT interval and syndromes. Adv Intern Med 1987; 32: 87-110.
12. Zipes DP. Proarrhythmic effects of antiarrthythmic drugs. Am J Cardiol 1987; 59: 26E-31E.
13. The Cardiac Arrhythmia Suppression Trial II Investigators. Effect of the antiarrhythmic agent moricizine on survival after myocardial infraction. N Engl J Med 1992; 327: 227-33.
14. Kr potassium channel. Cell 1995; 81: 299-307.
15. Roden DM. Arrhythmogenic potential of class III antiarrhythmic agents: comparison with class I agents. In: Singh BN, ed. Control of Cardiac Arrhythmias by Lengthening Repolarization. Mount Kisco, NY: Future Publishing Company; 1988: 559-76.
16. June RA, Nasr I. Torsades de pointes with terfenadine ingestion. Am J Emerg Med 1997; 15: 542-3.
17. Koh KK, Rim MS, Yoon J, Kim SS. Torsade de pointes induced by terfenadine in a patient with long QT syndrome. J Electrocardiol 1994; 27: 343-6.
18. Roy M, Dumaine R, Brown AM. HERG, a primary human ventricular target of the nonsedating antihistamine terfenadine. Circulation 1996; 94: 817-23.
19. Suessbrich H, Waldegger S, Lang F, Busch AE. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole. FEBS Lett 1996; 385: 77-80.
20. 2+ channel current in rat ventricular myocytes by terfenadine. Circ Res 1997; 81: 202-10.
21. Barlow JB, Bosman CK, Cochrane JWC. Congenital cardiac arrhythmia. Lancet 1964; II: 531.
22. Garza LA, Vick RL, Nora JJ, McNamara DG. Heritable Q-T prolongation without deafness. Circulation 1970; 41: 39-48.
23. Keating MT, Atkinson D, Dunn C, Timothy K, Vincent GM, Leppert M. Consistent linkage of the long QT syndrome to the Harvey ras-1 locus on chromosome 11. Am J Hum Genet 1991; 49: 1335-9.
24. Towbin JA, Pagotto L, Siu B, et al. Romano-Ward long QT syndrome (RWLQTS): evidence of genetic heterogeneity. Pediatr Res 1992; 31: 23A.
25. Benhorin J, Kalman YM, Madina A, et al. Evidence of genetic heterogeneity in the long QT syndrome. Science 1993; 260: 1960-2.
26. Curran ME, Atkinson D, Timothy K, et al. Locus heterogeneity of autosomal dominant long QT syndrome. J Clin Invest 1993; 92: 799-803.